Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges
Author:
Affiliation:
1. Division of Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, New York, NY, USA
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Link
http://academic.oup.com/jac/article-pdf/73/11/2997/26144746/dky322.pdf
Reference20 articles.
1. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City;Bradford;Clin Infect Dis,2004
2. Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms — United States, 2006–2017;Woodworth;MMWR Morb Mortal Wkly Rep,2018
3. Rise and fall of KPC-producing Klebsiella pneumoniae in New York City;Abdallah;J Antimicrob Chemother,2016
4. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention;Schwaber;Clin Infect Dis,2011
5. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae;Lin;Clin Infect Dis,2013
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clonal background and routes of plasmid transmission underlie antimicrobial resistance features of bloodstream Klebsiella pneumoniae;Nature Communications;2024-08-14
2. Comparison of carbapenem-susceptible and carbapenem-resistant Enterobacterales at nine sites in the USA, 2013–2016: a resource for antimicrobial resistance investigators;Microbial Genomics;2023-11-21
3. Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016–2022;Emerging Infectious Diseases;2023-10
4. Trends of β-Lactamase Occurrence AmongEscherichia coliandKlebsiella pneumoniaein United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type;Open Forum Infectious Diseases;2023-01-27
5. In Vitro and In Vivo Activity of Amoxicillin–Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella pneumoniae;Microbial Drug Resistance;2022-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3